Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China · Delayed Price · Currency is CNY 5.12
+0.11 (2.20%)
Jun 1, 2026, 3:00 PM CST
SHA:600866 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 457.83 | 978.89 | 943.15 | 677.95 | 608.33 | 152.14 |
Depreciation & Amortization | 845.48 | 845.48 | 846.3 | 853.54 | 982.19 | 103.83 |
Other Amortization | 8.85 | 8.85 | 1.89 | 1.51 | 1.02 | 0.6 |
Loss (Gain) From Sale of Assets | 5.29 | 5.29 | -28.69 | -0.3 | -4.35 | -0.83 |
Asset Writedown & Restructuring Costs | 13.36 | 13.36 | 98.81 | 108.85 | 29.48 | -0.91 |
Loss (Gain) From Sale of Investments | -27.86 | -27.86 | -4.75 | -13.53 | -7.3 | -6.67 |
Provision & Write-off of Bad Debts | 9.51 | 9.51 | -4.56 | 5.75 | 3.23 | -2.86 |
Other Operating Activities | -473.77 | 145.21 | 395.81 | 286.13 | 893.32 | 91.45 |
Change in Accounts Receivable | -40.82 | -40.82 | 314.55 | 82.68 | 296.4 | 112.79 |
Change in Inventory | -208.76 | -208.76 | 228.01 | 1,056 | -878.41 | -5.99 |
Change in Accounts Payable | -430.77 | -430.77 | -371.31 | -1,020 | -243.24 | -260.78 |
Operating Cash Flow | 151.96 | 1,292 | 2,398 | 2,026 | 1,663 | 168.2 |
Operating Cash Flow Growth | -94.86% | -46.12% | 18.34% | 21.87% | 888.42% | -32.72% |
Capital Expenditures | -2,035 | -2,039 | -638.5 | -375.83 | -452.34 | -349.79 |
Sale of Property, Plant & Equipment | 3.19 | 3.22 | 9.5 | 0.19 | 13.37 | 23.48 |
Divestitures | - | - | - | - | - | 20.08 |
Investment in Securities | 297.62 | -390.58 | -238.81 | -491.86 | -350 | -11.09 |
Other Investing Activities | 27.38 | 16.68 | 3.66 | 8.71 | 0.41 | 2.89 |
Investing Cash Flow | -1,707 | -2,409 | -864.15 | -858.79 | -788.57 | -314.44 |
Short-Term Debt Issued | - | 2,891 | - | - | - | - |
Long-Term Debt Issued | - | 2,150 | 3,135 | 3,706 | 4,918 | 1,554 |
Total Debt Issued | 4,248 | 5,041 | 3,135 | 3,706 | 4,918 | 1,554 |
Long-Term Debt Repaid | - | -3,975 | -4,104 | -4,275 | -5,108 | -1,181 |
Net Debt Issued (Repaid) | 782.35 | 1,066 | -969.38 | -569.23 | -189.84 | 373.41 |
Issuance of Common Stock | 87.79 | 87.79 | 61.65 | 50 | - | - |
Common Dividends Paid | -730.91 | -726.54 | -744.67 | -152.22 | -367.51 | -90.72 |
Other Financing Activities | 814.74 | 872.45 | -45.68 | -30.26 | -49.2 | -133.79 |
Financing Cash Flow | 953.97 | 1,300 | -1,698 | -701.71 | -606.54 | 148.9 |
Foreign Exchange Rate Adjustments | -18.86 | -14.04 | 29.47 | -0.74 | -66.91 | 5.55 |
Net Cash Flow | -620.19 | 168.75 | -135.01 | 464.86 | 200.48 | 8.22 |
Free Cash Flow | -1,883 | -746.52 | 1,759 | 1,650 | 1,210 | -181.59 |
Free Cash Flow Growth | - | - | 6.60% | 36.37% | - | - |
Free Cash Flow Margin | -12.07% | -4.70% | 10.15% | 9.50% | 6.92% | -4.46% |
Free Cash Flow Per Share | -1.13 | -0.45 | 1.06 | 0.99 | 1.02 | -0.23 |
Cash Income Tax Paid | - | 66.64 | 8.93 | -121.12 | -123.99 | -15.41 |
Levered Free Cash Flow | -2,748 | -1,392 | 2,000 | 363.03 | 982.21 | 6.55 |
Unlevered Free Cash Flow | -2,701 | -1,342 | 2,068 | 471.45 | 1,134 | 58.65 |
Change in Working Capital | -686.72 | -686.72 | 149.78 | 106.2 | -843.4 | -168.55 |